OptimizeRx (OPRX) Equity Ratio (2016 - 2025)
OptimizeRx (OPRX) has disclosed Equity Ratio for 16 consecutive years, with 0.73 as the latest value for Q4 2025.
- Quarterly Equity Ratio rose 6.09% to 0.73 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.73 through Dec 2025, up 6.09% year-over-year, with the annual reading at 0.73 for FY2025, 6.09% up from the prior year.
- Equity Ratio hit 0.73 in Q4 2025 for OptimizeRx, up from 0.72 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q1 2021 to a low of 0.68 in Q4 2024.
- Historically, Equity Ratio has averaged 0.84 across 5 years, with a median of 0.93 in 2022.
- Biggest five-year swings in Equity Ratio: increased 23.11% in 2021 and later fell 26.67% in 2024.
- Year by year, Equity Ratio stood at 0.93 in 2021, then increased by 0.51% to 0.94 in 2022, then fell by 26.31% to 0.69 in 2023, then dropped by 0.96% to 0.68 in 2024, then rose by 6.09% to 0.73 in 2025.
- Business Quant data shows Equity Ratio for OPRX at 0.73 in Q4 2025, 0.72 in Q3 2025, and 0.7 in Q2 2025.